A citation-based method for searching scientific literature

L A Piras, F Riccardo, S Iussich, L Maniscalco, F Gattino, M Martano, E Morello, S Lorda Mayayo, V Rolih, F Garavaglia, R De Maria, E Lardone, F Collivignarelli, D Mignacca, D Giacobino, S Ferrone, F Cavallo, P Buracco. Vet Comp Oncol 2017
Times Cited: 24







List of co-cited articles
287 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA.
Federica Riccardo, Selina Iussich, Lorella Maniscalco, Saray Lorda Mayayo, Giuseppe La Rosa, Maddalena Arigoni, Raffaella De Maria, Francesca Gattino, Stefania Lanzardo, Elena Lardone,[...]. Clin Cancer Res 2014
45
70

Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
Deborah A Grosenbaugh, A Timothy Leard, Philip J Bergman, Mary K Klein, Karri Meleo, Steven Susaneck, Paul R Hess, Monika K Jankowski, Pamela D Jones, Nicole F Leibman,[...]. Am J Vet Res 2011
132
66

A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
J M Ottnod, R C Smedley, R Walshaw, J G Hauptman, M Kiupel, J E Obradovich. Vet Comp Oncol 2013
74
58

Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001-2012).
Sarah E Boston, Xiaomin Lu, William T N Culp, Vincenzo Montinaro, Giorgio Romanelli, Robert M Dudley, Julius M Liptak, Lisa A Mestrinho, Paolo Buracco. J Am Vet Med Assoc 2014
61
54


Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
Saray Lorda Mayayo, Simone Prestigio, Lorella Maniscalco, Giuseppe La Rosa, Arianna Aricò, Raffaella De Maria, Federica Cavallo, Soldano Ferrone, Paolo Buracco, Selina Iussich. Vet J 2011
29
41

Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
Philip J Bergman, Joanne McKnight, Andrew Novosad, Sarah Charney, John Farrelly, Diane Craft, Michelle Wulderk, Yusuf Jeffers, Michel Sadelain, Ann E Hohenhaus,[...]. Clin Cancer Res 2003
231
41

Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).
Joanne L Tuohy, Laura E Selmic, Deanna R Worley, Nicole P Ehrhart, Stephen J Withrow. J Am Vet Med Assoc 2014
58
41

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.
A N Alexander, M K Huelsmeyer, Ann Mitzey, R R Dubielzig, I D Kurzman, E G Macewen, D M Vail. Cancer Immunol Immunother 2006
54
37

CSPG4: a prototype oncoantigen for translational immunotherapy studies.
Valeria Rolih, Giuseppina Barutello, Selina Iussich, Raffaella De Maria, Elena Quaglino, Paolo Buracco, Federica Cavallo, Federica Riccardo. J Transl Med 2017
34
37

Use of the melanoma vaccine in 38 dogs: The South African experience.
Joanne L McLean, Remo G Lobetti. J S Afr Vet Assoc 2015
18
44

CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.
Matthew A Price, Leah E Colvin Wanshura, Jianbo Yang, Jennifer Carlson, Bo Xiang, Guiyuan Li, Soldano Ferrone, Arkadiusz Z Dudek, Eva A Turley, James B McCarthy. Pigment Cell Melanoma Res 2011
105
33

A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation.
David R Proulx, David M Ruslander, Richard K Dodge, Marlene L Hauck, Laurel E Williams, Birgitte Horn, G Sylvester Price, Donald E Thrall. Vet Radiol Ultrasound 2003
95
33

A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma.
Naoya Maekawa, Satoru Konnai, Satoshi Takagi, Yumiko Kagawa, Tomohiro Okagawa, Asami Nishimori, Ryoyo Ikebuchi, Yusuke Izumi, Tatsuya Deguchi, Chie Nakajima,[...]. Sci Rep 2017
64
33

Comparative Aspects of Canine Melanoma.
Adriana Tomoko Nishiya, Cristina Oliveira Massoco, Claudia Ronca Felizzola, Eduardo Perlmann, Karen Batschinski, Marcello Vannucci Tedardi, Jéssica Soares Garcia, Priscila Pedra Mendonça, Tarso Felipe Teixeira, Maria Lucia Zaidan Dagli. Vet Sci 2016
56
33

Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
S Verganti, D Berlato, L Blackwood, I Amores-Fuster, G A Polton, R Elders, R Doyle, A Taylor, S Murphy. J Small Anim Pract 2017
29
29

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.
P J Bergman, M A Camps-Palau, J A McKnight, N F Leibman, D M Craft, C Leung, J Liao, I Riviere, M Sadelain, A E Hohenhaus,[...]. Vaccine 2006
166
29

Canine oral melanoma.
Philip J Bergman. Clin Tech Small Anim Pract 2007
119
29

Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
F Quintin-Colonna, P Devauchelle, D Fradelizi, B Mourot, T Faure, P Kourilsky, C Roth, M Mehtali. Gene Ther 1996
55
25


Cytokine-Enhanced Vaccine and Interferon-β plus Suicide Gene Therapy as Surgery Adjuvant Treatments for Spontaneous Canine Melanoma.
Liliana M E Finocchiaro, Chiara Fondello, María L Gil-Cardeza, Úrsula A Rossi, Marcela S Villaverde, María D Riveros, Gerardo C Glikin. Hum Gene Ther 2015
26
25

Translation of new cancer treatments from pet dogs to humans.
Melissa Paoloni, Chand Khanna. Nat Rev Cancer 2008
444
25


Cancer immunology and canine malignant melanoma: A comparative review.
Matthew J Atherton, Joanna S Morris, Mark R McDermott, Brian D Lichty. Vet Immunol Immunopathol 2016
47
25

Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases.
J A Ramos-Vara, M E Beissenherz, M A Miller, G C Johnson, L W Pace, A Fard, S J Kottler. Vet Pathol 2000
171
25


Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation.
R C Smedley, W L Spangler, D G Esplin, B E Kitchell, P J Bergman, H-Y Ho, I L Bergin, M Kiupel. Vet Pathol 2011
120
25

A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
Nina Milevoj, Urša Lampreht Tratar, Ana Nemec, Andreja Brožič, Katarina Žnidar, Gregor Serša, Maja Čemažar, Nataša Tozon. Res Vet Sci 2019
23
26

Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006-2012).
Mifumi Kawabe, Takashi Mori, Yusuke Ito, Mami Murakami, Hiroki Sakai, Tokuma Yanai, Kohji Maruo. J Am Vet Med Assoc 2015
32
25

A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs.
Masaya Igase, Yuki Nemoto, Kazuhito Itamoto, Kenji Tani, Munekazu Nakaichi, Masashi Sakurai, Yusuke Sakai, Shunsuke Noguchi, Masahiro Kato, Toshihiro Tsukui,[...]. Sci Rep 2020
25
25

Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma.
Sara Westberg, Arian Sadeghi, Emma Svensson, Thomas Segall, Maria Dimopoulou, Olle Korsgren, Akseli Hemminki, Angelica S I Loskog, Thomas H Tötterman, Henrik von Euler. J Immunother 2013
43
20

Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma.
Nicola J Mason, Josephine S Gnanandarajah, Julie B Engiles, Falon Gray, Danielle Laughlin, Anita Gaurnier-Hausser, Anu Wallecha, Margie Huebner, Yvonne Paterson. Clin Cancer Res 2016
95
20

Clinical trials of immunogene therapy for spontaneous tumors in companion animals.
Gerardo Claudio Glikin, Liliana María Elena Finocchiaro. ScientificWorldJournal 2014
18
27

Theranostic impact of NG2/CSPG4 proteoglycan in cancer.
Pier Andrea Nicolosi, Alice Dallatomasina, Roberto Perris. Theranostics 2015
43
20

CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
Zeyana Rivera, Soldano Ferrone, Xinhui Wang, Sandro Jube, Haining Yang, Harvey I Pass, Shreya Kanodia, Giovanni Gaudino, Michele Carbone. Clin Cancer Res 2012
63
20

The importance of comparative oncology in translational medicine.
Federica Riccardo, Luigi Aurisicchio, Joseph A Impellizeri, Federica Cavallo. Cancer Immunol Immunother 2015
25
20

Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.
Belen Hernandez, Hibret A Adissu, Bih-Rong Wei, Helen T Michael, Glenn Merlino, R Mark Simpson. Int J Mol Sci 2018
59
20

Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision.
G Dank, K M Rassnick, Y Sokolovsky, L D Garrett, G S Post, B E Kitchell, R K Sellon, M Kleiter, N Northrup, G Segev. Vet Comp Oncol 2014
39
20

Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
Pedro A Boria, Daryl J Murry, Peter F Bennett, Nita W Glickman, Paul W Snyder, Brenna L Merkel, Deborah L Schlittler, Anthony J Mutsaers, Rose M Thomas, Deborah W Knapp. J Am Vet Med Assoc 2004
78
20


Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000).
K M Rassnick, D M Ruslander, S M Cotter, R Al-Sarraf, D S Bruyette, R M Gamblin, K A Meleo, A S Moore. J Am Vet Med Assoc 2001
92
20


Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy.
Lidia Tarone, Giuseppina Barutello, Selina Iussich, Davide Giacobino, Elena Quaglino, Paolo Buracco, Federica Cavallo, Federica Riccardo. Cancer Immunol Immunother 2019
21
23

Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
Davide Giacobino, Mariateresa Camerino, Federica Riccardo, Federica Cavallo, Lidia Tarone, Marina Martano, Alfredo Dentini, Selina Iussich, Elena Lardone, Paolo Franci,[...]. Vet Comp Oncol 2021
9
55

Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
Michelle Turek, Tracy LaDue, Jayme Looper, Koichi Nagata, Keijiro Shiomitsu, Michele Keyerleber, Julia Buchholz, Tracy Gieger, Scott Hetzel. Vet Radiol Ultrasound 2020
12
41

Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma.
M Kazim Panjwani, Jenessa B Smith, Keith Schutsky, Josephine Gnanandarajah, Colleen M O'Connor, Daniel J Powell, Nicola J Mason. Mol Ther 2016
71
16

Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.
Jedd D Wolchok, Jianda Yuan, Alan N Houghton, Humilidad F Gallardo, Teresa S Rasalan, Jian Wang, Yan Zhang, Rajaram Ranganathan, Paul B Chapman, Susan E Krown,[...]. Mol Ther 2007
72
16

Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions.
Jeffry Cutrera, Glenn King, Pamela Jones, Kristin Kicenuik, Elias Gumpel, Xueqing Xia, Shulin Li. Curr Gene Ther 2015
15
26

Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs.
C A Manley, N F Leibman, J D Wolchok, I C Rivière, S Bartido, D M Craft, P J Bergman. J Vet Intern Med 2011
39
16

DNA vaccination against oncoantigens: A promise.
Manuela Iezzi, Elena Quaglino, Augusto Amici, Pier-Luigi Lollini, Guido Forni, Federica Cavallo. Oncoimmunology 2012
29
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.